Brainsway, an Israeli company specializing in Deep TMS (transcranial magnetic stimulation), has recently received FDA approval for their innovative treatment of depression. The company created a magnetic helmet that acts as a mini-MRI machine in order to stimulate brain activity.
Essentially, it is electro-convulsive therapy that may eventually be used as an alternative to anti-depressant medications. The FDA's current guidelines allow five sessions over the course of four to six weeks. And although the Deep TMS helmet has had multiple success stories throughout Europe, it is still unclear if this treatment alone can cease depression permanently.